Infectious Disease Diagnostics Market projected to grow with significant CAGR over the forecast peri
Posted: May 07, 2018
Infectious diseases caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. Infectious disease diagnostics are the procedures for identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making right medical decisions. Infectious disease diagnostics can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods.
The important factors that are helping the infectious disease diagnostics market grow are increase in number of incidences of malaria, dengue, HIV, demand of early and better diagnosis, increase in government funding for the establishment of diagnostic centers and technological advancements in the diagnostic procedures are expected to boost the infectious disease diagnostic market. In addition to this changing demographics, increase in R & D activities and advances in healthcare sectors is also helping the market of infectious disease diagnostics grow. However, high cost for the diagnostic procedures, lack of awareness about the innovative diagnostic procedures, lack of skilled professionals to perform diagnostic tests, and lack of reimbursement policies for several diagnostic test might hamper the infectious disease diagnostics market growth.
A sample of this report is available upon request @
The infectious disease diagnostics market has been categorized as below-
1. Test type
- Imaging Test
- Magnetic Resonance Imaging (MRI)
- Computed tomography (C.T)
- Laboratory Tests
- Blood Tests
- Urine Tests
- Stool Tests
- Spinal Tap
- Throat Swabs
2. Product type
- Assay Kits and Consumables
3. Infection type
- Sexually Transmitted Infectious Diseases
To view TOC of this report is available upon request @
Hospitals, diagnostic laboratories, home healthcare, ambulatory clinics, and others.
And lastly, geographically, global infectious disease diagnostics market has been divided into following regions- North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global infectious disease diagnostics market followed by Europe and Asia-Pacific. The largest share of North-America region is due to increase in the prevalence of infectious diseases especially in U.S. The European region is expected to emerge as significant market owing to improved healthcare infrastructure, and increase in prevalence of bacterial and viral diseases, which are expected to fuel the growth of the infectious disease diagnostics market in European region. Moreover, Asia-Pacific is a key region for the growth of global infectious disease diagnostics, due to the high prevalence of infectious diseases, and increasing in healthcare expenditure. Moreover, due to increase in incidence and prevalence of infectious diseases such as bacterial infections and sexually transmitted diseases and rise in population expected to drive significant growth of the infectious disease diagnostics market in Asia-Pacific region. Some of the key players in global infectious disease diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), BioMérieux SA (France), Thermo Fischer Scientific (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson & Company (U.S.), and DiaSorin S.p.A. (Italy) to name a few. In 2014, DiaSorin launched the new molecular diagnostic test for the detection of Toxoplasmosis. In 2015, FDA approved Bio-Rad’s BioPlex 2200 HIV antigen-antibody assay, used for detection of HIV antibodies and HIV antigens. In 2016, Abbott released Alinity, a blend of innovative diagnostic system across the immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics.
Need more information about this report @
Geographically, the global infectious disease diagnostics market is in the developing stage, with the development of new technologies and increasing prevalence of the deadly infectious disease by various players in the market. Innovation of technologically advanced devices with quick results, use of usage, accuracy, and low-cost are expected to boost global infectious disease diagnostics market. The majority of companies are making efforts to develop and commercialize cost-effective tools for the infectious disease diagnostics. Nowadays, the gold standard tests available for sexually transmitted disease and bacterial infection diagnosis, and these tests are expected to replace by molecular techniques in future.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
152 – 160 City Road,
London EC1V 2NX
Website @ https://www.precisionbusinessinsights.com